Literature DB >> 29445067

Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.

Masato Furuhashi1, Satoshi Yuda2, Atsuko Muranaka1, Mina Kawamukai1, Megumi Matsumoto1, Marenao Tanaka1, Norihito Moniwa1, Hirofumi Ohnishi1,3, Shigeyuki Saitoh1,4, Kazuaki Shimamoto5, Tetsuji Miura1.   

Abstract

BACKGROUND: Fatty acid-binding protein 4 (FABP4), which is expressed in both adipocytes and macrophages, is secreted from the cells and acts as an adipokine. An elevated circulating FABP4 level is associated with insulin resistance and atherosclerosis.Methods and 
Results: We investigated the causative association between FABP4 level and progression of atherosclerosis in subjects of the Tanno-Sobetsu Study, a population-based cohort. In 281 subjects without medication (male/female: 109/172) in the year 2010 or 2013, the carotid intima-media thickness (CIMT) assessed using carotid ultrasonography was significantly correlated with age, adiposity, blood pressure, renal dysfunction and levels of cholesterol, triglycerides, fasting glucose, HbA1c and FABP4 (r=0.331, P<0.001). Multiple regression analysis demonstrated that age, sex and FABP4 concentration were independent predictors of CIMT. A total of 78 (male/female: 29/49) of the 156 subjects in 2010 underwent carotid ultrasonography again in 2013. The change in CIMT each year during that 3-year period (mean±SD: 3.8±22.3 µm/year) was positively correlated with basal levels of high-sensitivity C-reactive protein (hsCRP) (r=0.231, P=0.046) and FABP4 (r=0.267, P=0.018) in 2010. After adjustment for age, sex and hsCRP level, the basal FABP4 level was independently associated with the change in CIMT per year.
CONCLUSIONS: FABP4 concentration is an independent predictor of the progression of carotid atherosclerosis.

Entities:  

Keywords:  Adipokines; Atherosclerosis; Fatty acid-binding protein 4; Intima-media thickness

Mesh:

Substances:

Year:  2018        PMID: 29445067     DOI: 10.1253/circj.CJ-17-1295

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Serum fatty acid binding protein 4 is positively associated with early stroke recurrence in nondiabetic ischemic stroke.

Authors:  Bo Li; Jun Wu; Pengjun Jiang; Maogui Li; Qingyuan Liu; Yong Cao; Shuo Wang
Journal:  Aging (Albany NY)       Date:  2019-04-09       Impact factor: 5.682

Review 2.  Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.

Authors:  Masato Furuhashi
Journal:  J Atheroscler Thromb       Date:  2019-02-07       Impact factor: 4.928

3.  Association between adipocyte fatty acid-binding protein with left ventricular remodelling and diastolic function in type 2 diabetes: a prospective echocardiography study.

Authors:  Mei-Zhen Wu; Chi-Ho Lee; Yan Chen; Shuk-Yin Yu; Yu-Juan Yu; Qing-Wen Ren; Ho-Yi Carol Fong; Pui-Fai Wong; Hung-Fat Tse; Siu-Ling Karen Lam; Kai-Hang Yiu
Journal:  Cardiovasc Diabetol       Date:  2020-11-24       Impact factor: 9.951

4.  Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.

Authors:  Masato Furuhashi; Ichiro Sakuma; Takeshi Morimoto; Yukimura Higashiura; Akiko Sakai; Megumi Matsumoto; Mio Sakuma; Michio Shimabukuro; Takashi Nomiyama; Osamu Arasaki; Koichi Node; Shinichiro Ueda
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-23       Impact factor: 5.555

5.  Differences in circulating fatty acid-binding protein 4 concentration in the venous and capillary blood immediately after acute exercise.

Authors:  Shigeharu Numao; Ryota Uchida; Takashi Kurosaki; Masaki Nakagaichi
Journal:  J Physiol Anthropol       Date:  2021-02-10       Impact factor: 2.867

Review 6.  Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality.

Authors:  Chi-Ho Lee; David T W Lui; Karen S L Lam
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

Review 7.  Arterial stiffness: A brief review.

Authors:  Jen-Pi Tsai; Bang-Gee Hsu
Journal:  Tzu Chi Med J       Date:  2020-09-16

8.  Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study.

Authors:  Norie Saito; Masato Furuhashi; Masayuki Koyama; Yukimura Higashiura; Hiroshi Akasaka; Marenao Tanaka; Norihito Moniwa; Hirofumi Ohnishi; Shigeyuki Saitoh; Nobuyuki Ura; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

9.  Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.

Authors:  Masato Furuhashi; Ichiro Sakuma; Takeshi Morimoto; Yukimura Higashiura; Akiko Sakai; Megumi Matsumoto; Mio Sakuma; Michio Shimabukuro; Takashi Nomiyama; Osamu Arasaki; Koichi Node; Shinichiro Ueda
Journal:  Cardiovasc Diabetol       Date:  2020-06-15       Impact factor: 9.951

10.  Comparison of plasma fatty acid binding protein 4 concentration in venous and capillary blood.

Authors:  Shigeharu Numao; Yoshinori Nagasawa; Naomi Goromaru; Shunichi Tamaki
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.